TFF Pharmaceuticals, Inc. (TFFP)

1 member of Congress has disclosed 5 trades in TFF Pharmaceuticals, Inc. (TFFP) via STOCK Act filings. The most recent disclosure was a purchase by Tom Malinowski on 11 June 2020. Aggregate disclosed activity totals roughly $40K in purchases (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for TFFP
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for TFFP

5 transactions
Compliance: 40%
Tom Malinowski11 Jun 202026 Aug 2021PurchaseStock$1,001 - $15,000N/A
Tom Malinowski11 Jun 202026 Aug 2021PurchaseStock$1,001 - $15,000N/A
Tom Malinowski1 Jun 20205 Mar 2021PurchaseStock$1,001 - $15,000N/A
Tom Malinowski1 Jun 202030 Jul 2021PurchaseStock$1,001 - $15,000N/A
Tom Malinowski1 Jun 202026 Aug 2021PurchaseStock$1,001 - $15,000N/A

Stock Overview

Market Data

Market Cap

$288.8K

Volume

11.02M

Beta

1.32

P/E Ratio

-0.01

Fundamentals

EPS

$-5.50

Div. Yield

-

Open

$0.09

Day Range

$0.06 – $0.09

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Harlan F. Weisman
IPO Date
2019-10-25
Website
www.tffpharma.com

Operating as a clinical-stage biopharmaceutical company, TFF Pharmaceuticals, Inc., leverages its proprietary Thin Film Freezing (TFF) technology platform for the advancement and commercialization of therapeutic products across the United States and...

Earnings

Recent Quarters

Q3 202420 Nov
EPS$-0.81
Beat 0.0%
Q2 202414 Aug
EPS$-1.22
Beat 28.2%
Q1 202414 May
EPS$-2.40
Miss 9.1%
Q4 202328 Mar
EPS$-2.01
Miss 0.5%
Q3 202314 Nov
EPS$-2.25
Beat 18.2%
Q2 202315 Aug
EPS$-3.50
Beat 30.0%
Q1 202311 May
EPS$-4.75
Beat 5.0%
Q4 20227 Mar
EPS$-0.10
Beat 58.3%
Q3 202214 Nov
EPS$-7.25
Beat 6.5%
Q2 202211 Aug
EPS$-8.50
Miss 6.3%
Q1 202211 May
EPS$-8.25
Beat 13.2%
Q4 202124 Mar
EPS$-10.00
Miss 33.3%
Q3 202115 Nov
EPS$-8.50
Miss 142.9%
Q2 202112 Aug
EPS$-4.50
Beat 35.7%
Q1 202113 May
EPS$-8.25
Miss 37.5%
Q4 202010 Mar
EPS$-6.50
Miss 13.0%
Q3 20205 Nov
EPS$-6.00
Miss 20.0%
Q2 202013 Aug
EPS$-5.00
Beat 4.8%
Q1 202014 May
EPS$-5.00
Beat 16.7%
Q4 201926 Mar
EPS$-50.00
Q3 20199 Dec
EPS$-0.16
Q1 201930 Jun
EPS$-0.12
Q4 201831 Mar
EPS$-0.12
Q3 201831 Dec
EPS$-1.18
Q2 201830 Sept
EPS$-0.03
Q1 201830 Jun
EPS$-2.87
Q4 201731 Mar
EPS$-0.36

No dividend data available for this stock.

Stock Splits

Split History

19 Dec 2023Reverse Split
Ratio1:25

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about TFFP

Which members of Congress have traded TFFP?
1 member of Congress has disclosed 5 trade in TFF Pharmaceuticals, Inc. (TFFP) under the STOCK Act: Tom Malinowski.
When was TFFP most recently disclosed by Congress?
The most recent TFFP disclosure was a purchase by Tom Malinowski on 11 June 2020.
What is the total disclosed congressional trading volume for TFFP?
Members of Congress have disclosed approximately $40K in TFFP purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in TFFP?
This TFFP page updates as soon as new STOCK Act disclosures are filed for TFF Pharmaceuticals, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.